Page last updated: 2024-11-08

mirestrol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

miroestrol: from tuberous roots of P. candollei var. mirifica; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID165001
SCHEMBL ID3183639
MeSH IDM0042908

Synonyms (12)

Synonym
2618-41-9
miroestrol
inchi=1/c20h22o6/c1-18(2)11-6-19(24)7-14(22)20(25,16(11)17(19)23)12-8-26-13-5-9(21)3-4-10(13)15(12)18/h3-5,8,11,15-17,21,23-25h,6-7h2,1-2h3/t11-,15+,16-,17+,19+,20-/m0/s1
rjkldolociqyfs-prtisismsa-
2,12-methano-1h-benzo(b)naphtho(2,1-d)pyran-4(4ah)-one, 2,3,10b,11,12,12a-hexahydro-1,2,4a,8-tetrahydroxy-11,11-dimethyl-, (1r-(1alpha,2beta,4abeta,10bbeta,12alpha,12abeta))-
SCHEMBL3183639
2,3,10bbeta,11,12,12abeta-hexahydro-1alpha,2beta,4abeta,8-tetrahydroxy-11,11-dimethyl-2,12alpha-methano-1h-benzo[b]naphtho[2,1-d]pyran-4(4ah)-one
CS-0182693
Q5961470
(1s,3r,13s,16r,17r,18s)-7,13,16,17-tetrahydroxy-2,2-dimethyl-10-oxapentacyclo[14.2.1.03,12.04,9.013,18]nonadeca-4(9),5,7,11-tetraen-14-one
XM161777
HY-N9510
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (13.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's20 (66.67)24.3611
2020's6 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]